Global Central Nervous System Disease Drugs Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Central Nervous System Disease Drugs market size was estimated at USD 558.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Central Nervous System Disease Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Central Nervous System Disease Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Central Nervous System Disease Drugs market.
Global Central Nervous System Disease Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Biogen
Otsuka
Novartis
Teva Pharmaceutical
Johnson & Johnson
AstraZeneca
Merck
GSK
Eli Lilly and Company
Lundbeck
Takeda
Bristol Myers Squibb
Jiangsu Nhwa Pharmaceutical
Luye Pharma
Zhejiang Huahai Pharmaceutical
Chengdu Easton Biopharmaceuticals
Hansoh Pharmaceutical
Market Segmentation (by Type)
Antidepressants
Antipsychotics
Anti-Dementia Drugs
Anti-Parkinson's Drugs
Antiepileptic Drugs
Others
Market Segmentation (by Application)
Hospital and Clinic
Pharmacy
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Central Nervous System Disease Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Central Nervous System Disease Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Central Nervous System Disease Drugs market size was estimated at USD 558.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Central Nervous System Disease Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Central Nervous System Disease Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Central Nervous System Disease Drugs market.
Global Central Nervous System Disease Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Biogen
Otsuka
Novartis
Teva Pharmaceutical
Johnson & Johnson
AstraZeneca
Merck
GSK
Eli Lilly and Company
Lundbeck
Takeda
Bristol Myers Squibb
Jiangsu Nhwa Pharmaceutical
Luye Pharma
Zhejiang Huahai Pharmaceutical
Chengdu Easton Biopharmaceuticals
Hansoh Pharmaceutical
Market Segmentation (by Type)
Antidepressants
Antipsychotics
Anti-Dementia Drugs
Anti-Parkinson's Drugs
Antiepileptic Drugs
Others
Market Segmentation (by Application)
Hospital and Clinic
Pharmacy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Central Nervous System Disease Drugs Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Central Nervous System Disease Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Central Nervous System Disease Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Central Nervous System Disease Drugs
1.2 Key Market Segments
1.2.1 Central Nervous System Disease Drugs Segment by Type
1.2.2 Central Nervous System Disease Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Central Nervous System Disease Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Central Nervous System Disease Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Central Nervous System Disease Drugs Product Life Cycle
3.3 Global Central Nervous System Disease Drugs Sales by Manufacturers (2020-2025)
3.4 Global Central Nervous System Disease Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Central Nervous System Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Central Nervous System Disease Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Central Nervous System Disease Drugs Market Competitive Situation and Trends
3.8.1 Central Nervous System Disease Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Central Nervous System Disease Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM DISEASE DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Central Nervous System Disease Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Central Nervous System Disease Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Central Nervous System Disease Drugs Market
5.7 ESG Ratings of Leading Companies
6 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Central Nervous System Disease Drugs Sales Market Share by Type (2020-2025)
6.3 Global Central Nervous System Disease Drugs Market Size by Type (2020-2025)
6.4 Global Central Nervous System Disease Drugs Price by Type (2020-2025)
7 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Central Nervous System Disease Drugs Market Sales by Application (2020-2025)
7.3 Global Central Nervous System Disease Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Central Nervous System Disease Drugs Sales Growth Rate by Application (2020-2025)
8 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SALES BY REGION
8.1 Global Central Nervous System Disease Drugs Sales by Region
8.1.1 Global Central Nervous System Disease Drugs Sales by Region
8.1.2 Global Central Nervous System Disease Drugs Sales Market Share by Region
8.2 Global Central Nervous System Disease Drugs Market Size by Region
8.2.1 Global Central Nervous System Disease Drugs Market Size by Region
8.2.2 Global Central Nervous System Disease Drugs Market Size by Region
8.3 North America
8.3.1 North America Central Nervous System Disease Drugs Sales by Country
8.3.2 North America Central Nervous System Disease Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Central Nervous System Disease Drugs Sales by Country
8.4.2 Europe Central Nervous System Disease Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Central Nervous System Disease Drugs Sales by Region
8.5.2 Asia Pacific Central Nervous System Disease Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Central Nervous System Disease Drugs Sales by Country
8.6.2 South America Central Nervous System Disease Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Central Nervous System Disease Drugs Sales by Region
8.7.2 Middle East and Africa Central Nervous System Disease Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Central Nervous System Disease Drugs by Region(2020-2025)
9.2 Global Central Nervous System Disease Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Central Nervous System Disease Drugs Production
9.4.1 North America Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.4.2 North America Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Central Nervous System Disease Drugs Production
9.5.1 Europe Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Central Nervous System Disease Drugs Production (2020-2025)
9.6.1 Japan Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Central Nervous System Disease Drugs Production (2020-2025)
9.7.1 China Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.7.2 China Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Central Nervous System Disease Drugs Product Overview
10.1.3 Pfizer Central Nervous System Disease Drugs Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Biogen
10.2.1 Biogen Basic Information
10.2.2 Biogen Central Nervous System Disease Drugs Product Overview
10.2.3 Biogen Central Nervous System Disease Drugs Product Market Performance
10.2.4 Biogen Business Overview
10.2.5 Biogen SWOT Analysis
10.2.6 Biogen Recent Developments
10.3 Otsuka
10.3.1 Otsuka Basic Information
10.3.2 Otsuka Central Nervous System Disease Drugs Product Overview
10.3.3 Otsuka Central Nervous System Disease Drugs Product Market Performance
10.3.4 Otsuka Business Overview
10.3.5 Otsuka SWOT Analysis
10.3.6 Otsuka Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Central Nervous System Disease Drugs Product Overview
10.4.3 Novartis Central Nervous System Disease Drugs Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Basic Information
10.5.2 Teva Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.5.3 Teva Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.5.4 Teva Pharmaceutical Business Overview
10.5.5 Teva Pharmaceutical Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Central Nervous System Disease Drugs Product Overview
10.6.3 Johnson and Johnson Central Nervous System Disease Drugs Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 AstraZeneca
10.7.1 AstraZeneca Basic Information
10.7.2 AstraZeneca Central Nervous System Disease Drugs Product Overview
10.7.3 AstraZeneca Central Nervous System Disease Drugs Product Market Performance
10.7.4 AstraZeneca Business Overview
10.7.5 AstraZeneca Recent Developments
10.8 Merck
10.8.1 Merck Basic Information
10.8.2 Merck Central Nervous System Disease Drugs Product Overview
10.8.3 Merck Central Nervous System Disease Drugs Product Market Performance
10.8.4 Merck Business Overview
10.8.5 Merck Recent Developments
10.9 GSK
10.9.1 GSK Basic Information
10.9.2 GSK Central Nervous System Disease Drugs Product Overview
10.9.3 GSK Central Nervous System Disease Drugs Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 Eli Lilly and Company
10.10.1 Eli Lilly and Company Basic Information
10.10.2 Eli Lilly and Company Central Nervous System Disease Drugs Product Overview
10.10.3 Eli Lilly and Company Central Nervous System Disease Drugs Product Market Performance
10.10.4 Eli Lilly and Company Business Overview
10.10.5 Eli Lilly and Company Recent Developments
10.11 Lundbeck
10.11.1 Lundbeck Basic Information
10.11.2 Lundbeck Central Nervous System Disease Drugs Product Overview
10.11.3 Lundbeck Central Nervous System Disease Drugs Product Market Performance
10.11.4 Lundbeck Business Overview
10.11.5 Lundbeck Recent Developments
10.12 Takeda
10.12.1 Takeda Basic Information
10.12.2 Takeda Central Nervous System Disease Drugs Product Overview
10.12.3 Takeda Central Nervous System Disease Drugs Product Market Performance
10.12.4 Takeda Business Overview
10.12.5 Takeda Recent Developments
10.13 Bristol Myers Squibb
10.13.1 Bristol Myers Squibb Basic Information
10.13.2 Bristol Myers Squibb Central Nervous System Disease Drugs Product Overview
10.13.3 Bristol Myers Squibb Central Nervous System Disease Drugs Product Market Performance
10.13.4 Bristol Myers Squibb Business Overview
10.13.5 Bristol Myers Squibb Recent Developments
10.14 Jiangsu Nhwa Pharmaceutical
10.14.1 Jiangsu Nhwa Pharmaceutical Basic Information
10.14.2 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.14.3 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.14.4 Jiangsu Nhwa Pharmaceutical Business Overview
10.14.5 Jiangsu Nhwa Pharmaceutical Recent Developments
10.15 Luye Pharma
10.15.1 Luye Pharma Basic Information
10.15.2 Luye Pharma Central Nervous System Disease Drugs Product Overview
10.15.3 Luye Pharma Central Nervous System Disease Drugs Product Market Performance
10.15.4 Luye Pharma Business Overview
10.15.5 Luye Pharma Recent Developments
10.16 Zhejiang Huahai Pharmaceutical
10.16.1 Zhejiang Huahai Pharmaceutical Basic Information
10.16.2 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.16.3 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.16.4 Zhejiang Huahai Pharmaceutical Business Overview
10.16.5 Zhejiang Huahai Pharmaceutical Recent Developments
10.17 Chengdu Easton Biopharmaceuticals
10.17.1 Chengdu Easton Biopharmaceuticals Basic Information
10.17.2 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Overview
10.17.3 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Market Performance
10.17.4 Chengdu Easton Biopharmaceuticals Business Overview
10.17.5 Chengdu Easton Biopharmaceuticals Recent Developments
10.18 Hansoh Pharmaceutical
10.18.1 Hansoh Pharmaceutical Basic Information
10.18.2 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.18.3 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.18.4 Hansoh Pharmaceutical Business Overview
10.18.5 Hansoh Pharmaceutical Recent Developments
11 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET FORECAST BY REGION
11.1 Global Central Nervous System Disease Drugs Market Size Forecast
11.2 Global Central Nervous System Disease Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Central Nervous System Disease Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Central Nervous System Disease Drugs Market Size Forecast by Region
11.2.4 South America Central Nervous System Disease Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Central Nervous System Disease Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Central Nervous System Disease Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Central Nervous System Disease Drugs by Type (2026-2035)
12.1.2 Global Central Nervous System Disease Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Central Nervous System Disease Drugs by Type (2026-2035)
12.2 Global Central Nervous System Disease Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Central Nervous System Disease Drugs Sales (K MT) Forecast by Application
12.2.2 Global Central Nervous System Disease Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Central Nervous System Disease Drugs
1.2 Key Market Segments
1.2.1 Central Nervous System Disease Drugs Segment by Type
1.2.2 Central Nervous System Disease Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Central Nervous System Disease Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Central Nervous System Disease Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Central Nervous System Disease Drugs Product Life Cycle
3.3 Global Central Nervous System Disease Drugs Sales by Manufacturers (2020-2025)
3.4 Global Central Nervous System Disease Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Central Nervous System Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Central Nervous System Disease Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Central Nervous System Disease Drugs Market Competitive Situation and Trends
3.8.1 Central Nervous System Disease Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Central Nervous System Disease Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM DISEASE DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Central Nervous System Disease Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Central Nervous System Disease Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Central Nervous System Disease Drugs Market
5.7 ESG Ratings of Leading Companies
6 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Central Nervous System Disease Drugs Sales Market Share by Type (2020-2025)
6.3 Global Central Nervous System Disease Drugs Market Size by Type (2020-2025)
6.4 Global Central Nervous System Disease Drugs Price by Type (2020-2025)
7 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Central Nervous System Disease Drugs Market Sales by Application (2020-2025)
7.3 Global Central Nervous System Disease Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Central Nervous System Disease Drugs Sales Growth Rate by Application (2020-2025)
8 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SALES BY REGION
8.1 Global Central Nervous System Disease Drugs Sales by Region
8.1.1 Global Central Nervous System Disease Drugs Sales by Region
8.1.2 Global Central Nervous System Disease Drugs Sales Market Share by Region
8.2 Global Central Nervous System Disease Drugs Market Size by Region
8.2.1 Global Central Nervous System Disease Drugs Market Size by Region
8.2.2 Global Central Nervous System Disease Drugs Market Size by Region
8.3 North America
8.3.1 North America Central Nervous System Disease Drugs Sales by Country
8.3.2 North America Central Nervous System Disease Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Central Nervous System Disease Drugs Sales by Country
8.4.2 Europe Central Nervous System Disease Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Central Nervous System Disease Drugs Sales by Region
8.5.2 Asia Pacific Central Nervous System Disease Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Central Nervous System Disease Drugs Sales by Country
8.6.2 South America Central Nervous System Disease Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Central Nervous System Disease Drugs Sales by Region
8.7.2 Middle East and Africa Central Nervous System Disease Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Central Nervous System Disease Drugs by Region(2020-2025)
9.2 Global Central Nervous System Disease Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Central Nervous System Disease Drugs Production
9.4.1 North America Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.4.2 North America Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Central Nervous System Disease Drugs Production
9.5.1 Europe Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Central Nervous System Disease Drugs Production (2020-2025)
9.6.1 Japan Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Central Nervous System Disease Drugs Production (2020-2025)
9.7.1 China Central Nervous System Disease Drugs Production Growth Rate (2020-2025)
9.7.2 China Central Nervous System Disease Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Central Nervous System Disease Drugs Product Overview
10.1.3 Pfizer Central Nervous System Disease Drugs Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Biogen
10.2.1 Biogen Basic Information
10.2.2 Biogen Central Nervous System Disease Drugs Product Overview
10.2.3 Biogen Central Nervous System Disease Drugs Product Market Performance
10.2.4 Biogen Business Overview
10.2.5 Biogen SWOT Analysis
10.2.6 Biogen Recent Developments
10.3 Otsuka
10.3.1 Otsuka Basic Information
10.3.2 Otsuka Central Nervous System Disease Drugs Product Overview
10.3.3 Otsuka Central Nervous System Disease Drugs Product Market Performance
10.3.4 Otsuka Business Overview
10.3.5 Otsuka SWOT Analysis
10.3.6 Otsuka Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Central Nervous System Disease Drugs Product Overview
10.4.3 Novartis Central Nervous System Disease Drugs Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Basic Information
10.5.2 Teva Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.5.3 Teva Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.5.4 Teva Pharmaceutical Business Overview
10.5.5 Teva Pharmaceutical Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Central Nervous System Disease Drugs Product Overview
10.6.3 Johnson and Johnson Central Nervous System Disease Drugs Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 AstraZeneca
10.7.1 AstraZeneca Basic Information
10.7.2 AstraZeneca Central Nervous System Disease Drugs Product Overview
10.7.3 AstraZeneca Central Nervous System Disease Drugs Product Market Performance
10.7.4 AstraZeneca Business Overview
10.7.5 AstraZeneca Recent Developments
10.8 Merck
10.8.1 Merck Basic Information
10.8.2 Merck Central Nervous System Disease Drugs Product Overview
10.8.3 Merck Central Nervous System Disease Drugs Product Market Performance
10.8.4 Merck Business Overview
10.8.5 Merck Recent Developments
10.9 GSK
10.9.1 GSK Basic Information
10.9.2 GSK Central Nervous System Disease Drugs Product Overview
10.9.3 GSK Central Nervous System Disease Drugs Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 Eli Lilly and Company
10.10.1 Eli Lilly and Company Basic Information
10.10.2 Eli Lilly and Company Central Nervous System Disease Drugs Product Overview
10.10.3 Eli Lilly and Company Central Nervous System Disease Drugs Product Market Performance
10.10.4 Eli Lilly and Company Business Overview
10.10.5 Eli Lilly and Company Recent Developments
10.11 Lundbeck
10.11.1 Lundbeck Basic Information
10.11.2 Lundbeck Central Nervous System Disease Drugs Product Overview
10.11.3 Lundbeck Central Nervous System Disease Drugs Product Market Performance
10.11.4 Lundbeck Business Overview
10.11.5 Lundbeck Recent Developments
10.12 Takeda
10.12.1 Takeda Basic Information
10.12.2 Takeda Central Nervous System Disease Drugs Product Overview
10.12.3 Takeda Central Nervous System Disease Drugs Product Market Performance
10.12.4 Takeda Business Overview
10.12.5 Takeda Recent Developments
10.13 Bristol Myers Squibb
10.13.1 Bristol Myers Squibb Basic Information
10.13.2 Bristol Myers Squibb Central Nervous System Disease Drugs Product Overview
10.13.3 Bristol Myers Squibb Central Nervous System Disease Drugs Product Market Performance
10.13.4 Bristol Myers Squibb Business Overview
10.13.5 Bristol Myers Squibb Recent Developments
10.14 Jiangsu Nhwa Pharmaceutical
10.14.1 Jiangsu Nhwa Pharmaceutical Basic Information
10.14.2 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.14.3 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.14.4 Jiangsu Nhwa Pharmaceutical Business Overview
10.14.5 Jiangsu Nhwa Pharmaceutical Recent Developments
10.15 Luye Pharma
10.15.1 Luye Pharma Basic Information
10.15.2 Luye Pharma Central Nervous System Disease Drugs Product Overview
10.15.3 Luye Pharma Central Nervous System Disease Drugs Product Market Performance
10.15.4 Luye Pharma Business Overview
10.15.5 Luye Pharma Recent Developments
10.16 Zhejiang Huahai Pharmaceutical
10.16.1 Zhejiang Huahai Pharmaceutical Basic Information
10.16.2 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.16.3 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.16.4 Zhejiang Huahai Pharmaceutical Business Overview
10.16.5 Zhejiang Huahai Pharmaceutical Recent Developments
10.17 Chengdu Easton Biopharmaceuticals
10.17.1 Chengdu Easton Biopharmaceuticals Basic Information
10.17.2 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Overview
10.17.3 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Market Performance
10.17.4 Chengdu Easton Biopharmaceuticals Business Overview
10.17.5 Chengdu Easton Biopharmaceuticals Recent Developments
10.18 Hansoh Pharmaceutical
10.18.1 Hansoh Pharmaceutical Basic Information
10.18.2 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Overview
10.18.3 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Market Performance
10.18.4 Hansoh Pharmaceutical Business Overview
10.18.5 Hansoh Pharmaceutical Recent Developments
11 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET FORECAST BY REGION
11.1 Global Central Nervous System Disease Drugs Market Size Forecast
11.2 Global Central Nervous System Disease Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Central Nervous System Disease Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Central Nervous System Disease Drugs Market Size Forecast by Region
11.2.4 South America Central Nervous System Disease Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Central Nervous System Disease Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Central Nervous System Disease Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Central Nervous System Disease Drugs by Type (2026-2035)
12.1.2 Global Central Nervous System Disease Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Central Nervous System Disease Drugs by Type (2026-2035)
12.2 Global Central Nervous System Disease Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Central Nervous System Disease Drugs Sales (K MT) Forecast by Application
12.2.2 Global Central Nervous System Disease Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Central Nervous System Disease Drugs Market Size by Type (M USD)
Table 4. Global Central Nervous System Disease Drugs Market Size by Application
Table 5. Central Nervous System Disease Drugs Market Size Comparison by Region (M USD)
Table 6. Global Central Nervous System Disease Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Central Nervous System Disease Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Central Nervous System Disease Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Central Nervous System Disease Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Disease Drugs as of 2025)
Table 11. Global Market Central Nervous System Disease Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Central Nervous System Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Central Nervous System Disease Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Central Nervous System Disease Drugs Sales by Type (K MT)
Table 27. Global Central Nervous System Disease Drugs Market Size by Type (M USD)
Table 28. Global Central Nervous System Disease Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Central Nervous System Disease Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Central Nervous System Disease Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Central Nervous System Disease Drugs Market Share by Type (2020-2025)
Table 32. Global Central Nervous System Disease Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Central Nervous System Disease Drugs Sales (K MT) by Application
Table 34. Global Central Nervous System Disease Drugs Market Size by Application
Table 35. Global Central Nervous System Disease Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Central Nervous System Disease Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Central Nervous System Disease Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Central Nervous System Disease Drugs Market Share by Application (2020-2025)
Table 39. Global Central Nervous System Disease Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Central Nervous System Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Central Nervous System Disease Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Central Nervous System Disease Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Central Nervous System Disease Drugs Market Size by Region (2020-2025)
Table 44. North America Central Nervous System Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Central Nervous System Disease Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Central Nervous System Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Central Nervous System Disease Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Central Nervous System Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Central Nervous System Disease Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Central Nervous System Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Central Nervous System Disease Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Central Nervous System Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Central Nervous System Disease Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Central Nervous System Disease Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Central Nervous System Disease Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Central Nervous System Disease Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Central Nervous System Disease Drugs Product Overview
Table 64. Pfizer Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Biogen Basic Information
Table 69. Biogen Central Nervous System Disease Drugs Product Overview
Table 70. Biogen Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Biogen Business Overview
Table 72. Biogen SWOT Analysis
Table 73. Biogen Recent Developments
Table 74. Otsuka Basic Information
Table 75. Otsuka Central Nervous System Disease Drugs Product Overview
Table 76. Otsuka Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Otsuka Business Overview
Table 78. Otsuka SWOT Analysis
Table 79. Otsuka Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Central Nervous System Disease Drugs Product Overview
Table 82. Novartis Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Teva Pharmaceutical Basic Information
Table 86. Teva Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 87. Teva Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceutical Business Overview
Table 89. Teva Pharmaceutical Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Central Nervous System Disease Drugs Product Overview
Table 92. Johnson and Johnson Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. AstraZeneca Basic Information
Table 96. AstraZeneca Central Nervous System Disease Drugs Product Overview
Table 97. AstraZeneca Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Recent Developments
Table 100. Merck Basic Information
Table 101. Merck Central Nervous System Disease Drugs Product Overview
Table 102. Merck Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merck Business Overview
Table 104. Merck Recent Developments
Table 105. GSK Basic Information
Table 106. GSK Central Nervous System Disease Drugs Product Overview
Table 107. GSK Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GSK Business Overview
Table 109. GSK Recent Developments
Table 110. Eli Lilly and Company Basic Information
Table 111. Eli Lilly and Company Central Nervous System Disease Drugs Product Overview
Table 112. Eli Lilly and Company Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly and Company Business Overview
Table 114. Eli Lilly and Company Recent Developments
Table 115. Lundbeck Basic Information
Table 116. Lundbeck Central Nervous System Disease Drugs Product Overview
Table 117. Lundbeck Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Lundbeck Business Overview
Table 119. Lundbeck Recent Developments
Table 120. Takeda Basic Information
Table 121. Takeda Central Nervous System Disease Drugs Product Overview
Table 122. Takeda Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Takeda Business Overview
Table 124. Takeda Recent Developments
Table 125. Bristol Myers Squibb Basic Information
Table 126. Bristol Myers Squibb Central Nervous System Disease Drugs Product Overview
Table 127. Bristol Myers Squibb Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Bristol Myers Squibb Business Overview
Table 129. Bristol Myers Squibb Recent Developments
Table 130. Jiangsu Nhwa Pharmaceutical Basic Information
Table 131. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 132. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Jiangsu Nhwa Pharmaceutical Business Overview
Table 134. Jiangsu Nhwa Pharmaceutical Recent Developments
Table 135. Luye Pharma Basic Information
Table 136. Luye Pharma Central Nervous System Disease Drugs Product Overview
Table 137. Luye Pharma Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Luye Pharma Business Overview
Table 139. Luye Pharma Recent Developments
Table 140. Zhejiang Huahai Pharmaceutical Basic Information
Table 141. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 142. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Zhejiang Huahai Pharmaceutical Business Overview
Table 144. Zhejiang Huahai Pharmaceutical Recent Developments
Table 145. Chengdu Easton Biopharmaceuticals Basic Information
Table 146. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Overview
Table 147. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Chengdu Easton Biopharmaceuticals Business Overview
Table 149. Chengdu Easton Biopharmaceuticals Recent Developments
Table 150. Hansoh Pharmaceutical Basic Information
Table 151. Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 152. Hansoh Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Hansoh Pharmaceutical Business Overview
Table 154. Hansoh Pharmaceutical Recent Developments
Table 155. Global Central Nervous System Disease Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Central Nervous System Disease Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Central Nervous System Disease Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Central Nervous System Disease Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Central Nervous System Disease Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Central Nervous System Disease Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Central Nervous System Disease Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Central Nervous System Disease Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Central Nervous System Disease Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Central Nervous System Disease Drugs Market Size by Type (M USD)
Table 4. Global Central Nervous System Disease Drugs Market Size by Application
Table 5. Central Nervous System Disease Drugs Market Size Comparison by Region (M USD)
Table 6. Global Central Nervous System Disease Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Central Nervous System Disease Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Central Nervous System Disease Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Central Nervous System Disease Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Disease Drugs as of 2025)
Table 11. Global Market Central Nervous System Disease Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Central Nervous System Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Central Nervous System Disease Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Central Nervous System Disease Drugs Sales by Type (K MT)
Table 27. Global Central Nervous System Disease Drugs Market Size by Type (M USD)
Table 28. Global Central Nervous System Disease Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Central Nervous System Disease Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Central Nervous System Disease Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Central Nervous System Disease Drugs Market Share by Type (2020-2025)
Table 32. Global Central Nervous System Disease Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Central Nervous System Disease Drugs Sales (K MT) by Application
Table 34. Global Central Nervous System Disease Drugs Market Size by Application
Table 35. Global Central Nervous System Disease Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Central Nervous System Disease Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Central Nervous System Disease Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Central Nervous System Disease Drugs Market Share by Application (2020-2025)
Table 39. Global Central Nervous System Disease Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Central Nervous System Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Central Nervous System Disease Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Central Nervous System Disease Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Central Nervous System Disease Drugs Market Size by Region (2020-2025)
Table 44. North America Central Nervous System Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Central Nervous System Disease Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Central Nervous System Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Central Nervous System Disease Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Central Nervous System Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Central Nervous System Disease Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Central Nervous System Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Central Nervous System Disease Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Central Nervous System Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Central Nervous System Disease Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Central Nervous System Disease Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Central Nervous System Disease Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Central Nervous System Disease Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Central Nervous System Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Central Nervous System Disease Drugs Product Overview
Table 64. Pfizer Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Biogen Basic Information
Table 69. Biogen Central Nervous System Disease Drugs Product Overview
Table 70. Biogen Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Biogen Business Overview
Table 72. Biogen SWOT Analysis
Table 73. Biogen Recent Developments
Table 74. Otsuka Basic Information
Table 75. Otsuka Central Nervous System Disease Drugs Product Overview
Table 76. Otsuka Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Otsuka Business Overview
Table 78. Otsuka SWOT Analysis
Table 79. Otsuka Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Central Nervous System Disease Drugs Product Overview
Table 82. Novartis Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Teva Pharmaceutical Basic Information
Table 86. Teva Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 87. Teva Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceutical Business Overview
Table 89. Teva Pharmaceutical Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Central Nervous System Disease Drugs Product Overview
Table 92. Johnson and Johnson Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. AstraZeneca Basic Information
Table 96. AstraZeneca Central Nervous System Disease Drugs Product Overview
Table 97. AstraZeneca Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Recent Developments
Table 100. Merck Basic Information
Table 101. Merck Central Nervous System Disease Drugs Product Overview
Table 102. Merck Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merck Business Overview
Table 104. Merck Recent Developments
Table 105. GSK Basic Information
Table 106. GSK Central Nervous System Disease Drugs Product Overview
Table 107. GSK Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GSK Business Overview
Table 109. GSK Recent Developments
Table 110. Eli Lilly and Company Basic Information
Table 111. Eli Lilly and Company Central Nervous System Disease Drugs Product Overview
Table 112. Eli Lilly and Company Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly and Company Business Overview
Table 114. Eli Lilly and Company Recent Developments
Table 115. Lundbeck Basic Information
Table 116. Lundbeck Central Nervous System Disease Drugs Product Overview
Table 117. Lundbeck Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Lundbeck Business Overview
Table 119. Lundbeck Recent Developments
Table 120. Takeda Basic Information
Table 121. Takeda Central Nervous System Disease Drugs Product Overview
Table 122. Takeda Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Takeda Business Overview
Table 124. Takeda Recent Developments
Table 125. Bristol Myers Squibb Basic Information
Table 126. Bristol Myers Squibb Central Nervous System Disease Drugs Product Overview
Table 127. Bristol Myers Squibb Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Bristol Myers Squibb Business Overview
Table 129. Bristol Myers Squibb Recent Developments
Table 130. Jiangsu Nhwa Pharmaceutical Basic Information
Table 131. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 132. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Jiangsu Nhwa Pharmaceutical Business Overview
Table 134. Jiangsu Nhwa Pharmaceutical Recent Developments
Table 135. Luye Pharma Basic Information
Table 136. Luye Pharma Central Nervous System Disease Drugs Product Overview
Table 137. Luye Pharma Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Luye Pharma Business Overview
Table 139. Luye Pharma Recent Developments
Table 140. Zhejiang Huahai Pharmaceutical Basic Information
Table 141. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 142. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Zhejiang Huahai Pharmaceutical Business Overview
Table 144. Zhejiang Huahai Pharmaceutical Recent Developments
Table 145. Chengdu Easton Biopharmaceuticals Basic Information
Table 146. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Overview
Table 147. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Chengdu Easton Biopharmaceuticals Business Overview
Table 149. Chengdu Easton Biopharmaceuticals Recent Developments
Table 150. Hansoh Pharmaceutical Basic Information
Table 151. Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Overview
Table 152. Hansoh Pharmaceutical Central Nervous System Disease Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Hansoh Pharmaceutical Business Overview
Table 154. Hansoh Pharmaceutical Recent Developments
Table 155. Global Central Nervous System Disease Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Central Nervous System Disease Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Central Nervous System Disease Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Central Nervous System Disease Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Central Nervous System Disease Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Central Nervous System Disease Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Central Nervous System Disease Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Central Nervous System Disease Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Central Nervous System Disease Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Central Nervous System Disease Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Central Nervous System Disease Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Central Nervous System Disease Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Central Nervous System Disease Drugs Market Size (M USD), 2025-2035
Figure 5. Global Central Nervous System Disease Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Central Nervous System Disease Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Central Nervous System Disease Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Central Nervous System Disease Drugs Product Life Cycle
Figure 13. Central Nervous System Disease Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Central Nervous System Disease Drugs Revenue Share by Manufacturers in 2025
Figure 15. Central Nervous System Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Central Nervous System Disease Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Central Nervous System Disease Drugs Revenue in 2025
Figure 18. Industry Chain Map of Central Nervous System Disease Drugs
Figure 19. Global Central Nervous System Disease Drugs Market PEST Analysis
Figure 20. Global Central Nervous System Disease Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Central Nervous System Disease Drugs Market Share by Type
Figure 27. Sales Market Share of Central Nervous System Disease Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Central Nervous System Disease Drugs by Type in 2025
Figure 29. Market Share of Central Nervous System Disease Drugs by Type (2020-2025)
Figure 30. Market Share of Central Nervous System Disease Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Central Nervous System Disease Drugs Market Share by Application
Figure 33. Global Central Nervous System Disease Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Central Nervous System Disease Drugs Sales Market Share by Application in 2025
Figure 35. Global Central Nervous System Disease Drugs Market Share by Application (2020-2025)
Figure 36. Global Central Nervous System Disease Drugs Market Share by Application in 2025
Figure 37. Global Central Nervous System Disease Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Central Nervous System Disease Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Central Nervous System Disease Drugs Market Size by Region (2020-2025)
Figure 40. North America Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Central Nervous System Disease Drugs Sales Market Share by Country in 2024
Figure 43. North America Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Central Nervous System Disease Drugs Market Size by Country in 2024
Figure 45. U.S. Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Central Nervous System Disease Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Central Nervous System Disease Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Central Nervous System Disease Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Central Nervous System Disease Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Central Nervous System Disease Drugs Sales Market Share by Country in 2024
Figure 53. Europe Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Central Nervous System Disease Drugs Market Size by Country in 2024
Figure 55. Germany Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Central Nervous System Disease Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Central Nervous System Disease Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Central Nervous System Disease Drugs Market Size by Region in 2024
Figure 68. China Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Central Nervous System Disease Drugs Sales and Growth Rate (K MT)
Figure 79. South America Central Nervous System Disease Drugs Sales Market Share by Country in 2024
Figure 80. South America Central Nervous System Disease Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Central Nervous System Disease Drugs Market Size by Country in 2024
Figure 82. Brazil Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Central Nervous System Disease Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Central Nervous System Disease Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Central Nervous System Disease Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Central Nervous System Disease Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Central Nervous System Disease Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Central Nervous System Disease Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Central Nervous System Disease Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Central Nervous System Disease Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Central Nervous System Disease Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Central Nervous System Disease Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Central Nervous System Disease Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Central Nervous System Disease Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Central Nervous System Disease Drugs Market Size (M USD), 2025-2035
Figure 5. Global Central Nervous System Disease Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Central Nervous System Disease Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Central Nervous System Disease Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Central Nervous System Disease Drugs Product Life Cycle
Figure 13. Central Nervous System Disease Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Central Nervous System Disease Drugs Revenue Share by Manufacturers in 2025
Figure 15. Central Nervous System Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Central Nervous System Disease Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Central Nervous System Disease Drugs Revenue in 2025
Figure 18. Industry Chain Map of Central Nervous System Disease Drugs
Figure 19. Global Central Nervous System Disease Drugs Market PEST Analysis
Figure 20. Global Central Nervous System Disease Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Central Nervous System Disease Drugs Market Share by Type
Figure 27. Sales Market Share of Central Nervous System Disease Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Central Nervous System Disease Drugs by Type in 2025
Figure 29. Market Share of Central Nervous System Disease Drugs by Type (2020-2025)
Figure 30. Market Share of Central Nervous System Disease Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Central Nervous System Disease Drugs Market Share by Application
Figure 33. Global Central Nervous System Disease Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Central Nervous System Disease Drugs Sales Market Share by Application in 2025
Figure 35. Global Central Nervous System Disease Drugs Market Share by Application (2020-2025)
Figure 36. Global Central Nervous System Disease Drugs Market Share by Application in 2025
Figure 37. Global Central Nervous System Disease Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Central Nervous System Disease Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Central Nervous System Disease Drugs Market Size by Region (2020-2025)
Figure 40. North America Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Central Nervous System Disease Drugs Sales Market Share by Country in 2024
Figure 43. North America Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Central Nervous System Disease Drugs Market Size by Country in 2024
Figure 45. U.S. Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Central Nervous System Disease Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Central Nervous System Disease Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Central Nervous System Disease Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Central Nervous System Disease Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Central Nervous System Disease Drugs Sales Market Share by Country in 2024
Figure 53. Europe Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Central Nervous System Disease Drugs Market Size by Country in 2024
Figure 55. Germany Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Central Nervous System Disease Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Central Nervous System Disease Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Central Nervous System Disease Drugs Market Size by Region in 2024
Figure 68. China Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Central Nervous System Disease Drugs Sales and Growth Rate (K MT)
Figure 79. South America Central Nervous System Disease Drugs Sales Market Share by Country in 2024
Figure 80. South America Central Nervous System Disease Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Central Nervous System Disease Drugs Market Size by Country in 2024
Figure 82. Brazil Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Central Nervous System Disease Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Central Nervous System Disease Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Central Nervous System Disease Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Central Nervous System Disease Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Central Nervous System Disease Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Central Nervous System Disease Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Central Nervous System Disease Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Central Nervous System Disease Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Central Nervous System Disease Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Central Nervous System Disease Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Central Nervous System Disease Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Central Nervous System Disease Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Central Nervous System Disease Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Central Nervous System Disease Drugs Market Share Forecast by Application (2026-2035)
